Injectable medications for obesity found to produce smaller weight loss in a real-world setting
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or use lower maintenance dosages. ...
Jun 10, 2025
0
37









